SE8903625L - Antibacterial composition - Google Patents
Antibacterial compositionInfo
- Publication number
- SE8903625L SE8903625L SE8903625A SE8903625A SE8903625L SE 8903625 L SE8903625 L SE 8903625L SE 8903625 A SE8903625 A SE 8903625A SE 8903625 A SE8903625 A SE 8903625A SE 8903625 L SE8903625 L SE 8903625L
- Authority
- SE
- Sweden
- Prior art keywords
- antibacterial composition
- infections
- caused
- milk
- milks
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- A23J1/202—Casein or caseinates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Pulmonology (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8903625A SE465109B (sv) | 1989-10-30 | 1989-10-30 | Antibakteriell komposition |
KR1019910700615A KR920700678A (ko) | 1989-10-30 | 1990-10-30 | 항-박테리아 성분물 |
PCT/SE1990/000702 WO1991006308A1 (en) | 1989-10-30 | 1990-10-30 | A casein fraction for therapeutic, profylactic and/or diagnostic use in infections of the respiratory tract |
JP2515465A JPH04503077A (ja) | 1989-10-30 | 1990-10-30 | 抗菌組成物 |
HU912203A HU212935B (en) | 1989-10-30 | 1990-10-30 | Process for producing pharmaceutical compositions, medicinal human aliments and animal food containing casein |
AT90916537T ATE170754T1 (de) | 1989-10-30 | 1990-10-30 | Eine caseinfraktion zur therapeutischen vorbeugenden und/oder diagnostischen verwendung bei atemweginfektionen |
AU66470/90A AU633647B2 (en) | 1989-10-30 | 1990-10-30 | A casein fraction for therapeutic, profylactic and/or diagnostic use in infections of the respiratory tract |
EP90916537A EP0454813B1 (en) | 1989-10-30 | 1990-10-30 | A casein fraction for therapeutic, prophylactic and/or diagnostic use in infections of the respiratory tract |
ES90916537T ES2121755T3 (es) | 1989-10-30 | 1990-10-30 | Fraccion de caseina para uso terapeutico, profilactico y/o diagnostico en infecciones del tracto respiratorio. |
DK90916537T DK0454813T3 (da) | 1989-10-30 | 1990-10-30 | Caseinfraktion til terapeutisk, profylaktisk og/eller diagnostisk anvendelse ved infektioner i åndedrætssystemet |
CA002044244A CA2044244A1 (en) | 1989-10-30 | 1990-10-30 | Antibacterial composition |
DE69032646T DE69032646T2 (de) | 1989-10-30 | 1990-10-30 | Eine caseinfraktion zur therapeutischen vorbeugenden und/oder diagnostischen verwendung bei atemweginfektionen |
NO91912391A NO912391L (no) | 1989-10-30 | 1991-06-19 | Kaseinfraksjon for terapeutisk, profylaktisk og/eller diagnostisk anvendelse paa infeksjoner i aandedrettsorganene. |
SU914895868A RU2035913C1 (ru) | 1989-10-30 | 1991-06-28 | Средство, ингибирующее связывание s.pneumoniae и/или h. influenzae, и композиция, содержащая это средство |
FI913154A FI102516B1 (sv) | 1989-10-30 | 1991-06-28 | Förfarande för framställning av en kaseinfraktion med adhesionsinhiberande verkan på bakterier |
US08/880,132 US5968901A (en) | 1989-10-30 | 1997-06-20 | Antibacterial composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8903625A SE465109B (sv) | 1989-10-30 | 1989-10-30 | Antibakteriell komposition |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8903625D0 SE8903625D0 (sv) | 1989-10-30 |
SE8903625L true SE8903625L (sv) | 1991-05-01 |
SE465109B SE465109B (sv) | 1991-07-29 |
Family
ID=20377332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8903625A SE465109B (sv) | 1989-10-30 | 1989-10-30 | Antibakteriell komposition |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0454813B1 (sv) |
JP (1) | JPH04503077A (sv) |
KR (1) | KR920700678A (sv) |
AT (1) | ATE170754T1 (sv) |
AU (1) | AU633647B2 (sv) |
CA (1) | CA2044244A1 (sv) |
DE (1) | DE69032646T2 (sv) |
DK (1) | DK0454813T3 (sv) |
ES (1) | ES2121755T3 (sv) |
FI (1) | FI102516B1 (sv) |
HU (1) | HU212935B (sv) |
NO (1) | NO912391L (sv) |
RU (1) | RU2035913C1 (sv) |
SE (1) | SE465109B (sv) |
WO (1) | WO1991006308A1 (sv) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5506209A (en) * | 1994-05-26 | 1996-04-09 | Abbott Laboratories | Product for inhibition of infection of mammalian cells by respiratory syncytial virus |
US5643880A (en) * | 1994-05-26 | 1997-07-01 | Abbott Laboratories | Product for inhibition of attachment of H. influenzae to human cells |
US5538952A (en) * | 1994-05-26 | 1996-07-23 | Abbott Laboratories | Inhibition of infection of mammalian cells by respiratory syncytial virus |
US5707968A (en) * | 1994-05-26 | 1998-01-13 | Abbott Laboratories | Inhibition of attachment of H.influenzae to human cells |
WO1995032728A1 (en) * | 1994-05-26 | 1995-12-07 | Abbott Laboratories | Inhibition of attachment of h. influenzae to human cells |
EP0760674A1 (en) * | 1994-05-26 | 1997-03-12 | Abbott Laboratories | Inhibition of infection of mammalian cells by respiratory syncytial virus |
US5942254A (en) * | 1995-02-27 | 1999-08-24 | Abbott Laboratories | Phosphorylated recombinant human β-casein expressed in a bacterial system |
EP0862450A2 (en) * | 1995-11-06 | 1998-09-09 | Abbott Laboratories | A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein |
DE69629487D1 (de) * | 1995-11-06 | 2003-09-18 | Abbott Lab | Phosphoryliertes rekombinantes menschliches beta-kasein für die hemmung der anheftung von h. influenzae an menschlichen zellen |
AUPP494798A0 (en) | 1998-07-29 | 1998-08-20 | Pacific Biolink Pty Limited | Protective protein formulation |
EP1567117B1 (en) | 2002-11-26 | 2012-02-08 | The University of Chicago | Prevention and treatment of microbe-mediated epithelial disorders |
WO2009009156A2 (en) * | 2007-07-06 | 2009-01-15 | Laclede, Inc. | Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1496671A (en) * | 1975-03-27 | 1977-12-30 | Grindstedvaerket As | Anti-cancer-active sour milk fraction |
FR2491334A1 (fr) * | 1980-10-03 | 1982-04-09 | Inst Nat Sante Rech Med | Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant |
FR2592769B1 (fr) * | 1986-01-10 | 1990-10-12 | Agronomique Inst Nat Rech | Procede d'obtention d'une matiere enrichie en caseine beta, appareillage pour la mise en oeuvre de ce procede, et application des produits obtenus par ce procede comme aliments, complements alimentaires ou additifs en industrie alimentaire et pharmaceutique ou dans la preparation de peptides a activite physiologique |
JP2631470B2 (ja) * | 1987-05-15 | 1997-07-16 | 雪印乳業株式会社 | 感染防御剤 |
-
1989
- 1989-10-30 SE SE8903625A patent/SE465109B/sv not_active IP Right Cessation
-
1990
- 1990-10-30 AU AU66470/90A patent/AU633647B2/en not_active Ceased
- 1990-10-30 DE DE69032646T patent/DE69032646T2/de not_active Expired - Fee Related
- 1990-10-30 EP EP90916537A patent/EP0454813B1/en not_active Expired - Lifetime
- 1990-10-30 ES ES90916537T patent/ES2121755T3/es not_active Expired - Lifetime
- 1990-10-30 AT AT90916537T patent/ATE170754T1/de not_active IP Right Cessation
- 1990-10-30 CA CA002044244A patent/CA2044244A1/en not_active Abandoned
- 1990-10-30 WO PCT/SE1990/000702 patent/WO1991006308A1/en active IP Right Grant
- 1990-10-30 KR KR1019910700615A patent/KR920700678A/ko not_active Application Discontinuation
- 1990-10-30 JP JP2515465A patent/JPH04503077A/ja active Pending
- 1990-10-30 DK DK90916537T patent/DK0454813T3/da active
- 1990-10-30 HU HU912203A patent/HU212935B/hu not_active IP Right Cessation
-
1991
- 1991-06-19 NO NO91912391A patent/NO912391L/no unknown
- 1991-06-28 RU SU914895868A patent/RU2035913C1/ru active
- 1991-06-28 FI FI913154A patent/FI102516B1/sv active
Also Published As
Publication number | Publication date |
---|---|
CA2044244A1 (en) | 1991-05-01 |
ES2121755T3 (es) | 1998-12-16 |
AU6647090A (en) | 1991-05-31 |
RU2035913C1 (ru) | 1995-05-27 |
SE465109B (sv) | 1991-07-29 |
NO912391D0 (no) | 1991-06-19 |
EP0454813B1 (en) | 1998-09-09 |
NO912391L (no) | 1991-06-19 |
FI913154A0 (fi) | 1991-06-28 |
FI102516B (sv) | 1998-12-31 |
EP0454813A1 (en) | 1991-11-06 |
AU633647B2 (en) | 1993-02-04 |
SE8903625D0 (sv) | 1989-10-30 |
FI102516B1 (sv) | 1998-12-31 |
WO1991006308A1 (en) | 1991-05-16 |
JPH04503077A (ja) | 1992-06-04 |
DE69032646D1 (de) | 1998-10-15 |
ATE170754T1 (de) | 1998-09-15 |
DE69032646T2 (de) | 1999-05-27 |
DK0454813T3 (da) | 1999-02-01 |
KR920700678A (ko) | 1992-08-10 |
HU212935B (en) | 1996-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8903625D0 (sv) | Antibacterial composition | |
EP0909814A3 (en) | Use of protein kinases for the diagnosis and treatment of Alzheimer's disease | |
ATE165395T1 (de) | Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen | |
AU7614196A (en) | Therapeutic and diagnostic compositions | |
BR0214705A (pt) | Composição, seu uso, método para prevenção ou tratamento de doença neurodegenerativa, e kit | |
EP1731166A3 (en) | Streptococcus pneumoniae proteins and vaccines | |
BR0013814A (pt) | Métodos de tratamentos de um paciente humano suscetìvel a ou diagnosticado com uma doença com anticorpos anti-erbb2, artigos industrializados, métodos de tratamentos de câncer em pacientes humanos e usos do anticorpo anti-erbb2 | |
EP2261358A3 (en) | Novel streptococcus antigen | |
CA2132953A1 (en) | Monospecific polyclonal antibodies to shiga-like toxins | |
EP1757697A3 (en) | Group B streptococcus antigens | |
MX9203629A (es) | Composiciones de anticuerpos monoclonales para el tratamiento profilactico o terapeutico de infecciones bacterianas debidas a estreptococos del grupo b. | |
DE69628336D1 (de) | Behandlung und diagnose helicobacter pylori infektionen | |
KR950700726A (ko) | 치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use) | |
WO2000058475A3 (en) | Streptococcus pneumoniae antigens | |
ATE43500T1 (de) | Herstellung von antikoerpern. | |
ES2136206T3 (es) | Composicion antibacteriana que contiene alfalactalbumina multimerica. | |
WO1992021697A3 (en) | Diagnostic peptides derived from m.tuberculosis antigens | |
DE69002946D1 (de) | Paracetamol enthaltende arzneizubereitung. | |
WO2000015797A3 (en) | Compositions and methods for the treatment of immune related diseases | |
Ginsburg | Streptococcus. | |
ATE27822T1 (de) | Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus. | |
AP1638A (en) | Peptide mimics of conserved gonococcal epitopes and methods and compositions using them. | |
Diallo et al. | Neurological Complications of Typhoid Fever: Case of Guillain-Barre'Syndrome about an Observation in Dakar, Senegal | |
WO2002061066A8 (en) | Method for producing an enzyme from a novel source | |
Rosembaum et al. | Curative effect of oral decontamination in septicaemia from intestinal origin. Traitement de deux septicemies d'origine intestinale, par une decontamination digestive, associee a l'antibiotherapie par voie generale. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8903625-5 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 8903625-5 Format of ref document f/p: F |